Rani Therapeutics Company Top Insiders

Rani Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.5683) % which means that it has lost $0.5683 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.2535) %, meaning that it created substantial loss on money invested by shareholders. Rani Therapeutics' management efficiency ratios could be used to measure how well Rani Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.62. The current Return On Capital Employed is estimated to decrease to -1.39. As of now, Rani Therapeutics' Fixed Asset Turnover is increasing as compared to previous years. The Rani Therapeutics' current Asset Turnover is estimated to increase to 0.03, while Non Current Assets Total are projected to decrease to under 6.5 M. The current Common Stock Shares Outstanding is estimated to decrease to about 23.9 M. The Rani Therapeutics' current Net Loss is estimated to increase to about (52.3 M)

Rani Therapeutics Workforce Comparison

Rani Therapeutics Insider Trading

Rani Therapeutics Notable Stakeholders

The success or failure of an entity such as Rani Therapeutics often depends on how effective the management is. Rani Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Rani management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Rani management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

When running Rani Therapeutics' price analysis, check to measure Rani Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rani Therapeutics is operating at the current time. Most of Rani Therapeutics' value examination focuses on studying past and present price action to predict the probability of Rani Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rani Therapeutics' price. Additionally, you may evaluate how the addition of Rani Therapeutics to your portfolios can decrease your overall portfolio volatility.